North America Genome Editing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Genome Editing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Genome Editing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Genome Editing Market Regional Analysis

6.2 North America Genome Editing Market Revenue 2019-2028 (US$ Million)

6.3 North America Genome Editing Market Forecast Analysis

7. North America Genome Editing Market Analysis – by Technology

7.1 CRISPR

7.1.1 Overview
7.1.2 CRISPR: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 TALEN

7.2.1 Overview
7.2.2 TALEN: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Antisense

7.3.1 Overview
7.3.2 Antisense: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Genome Editing Market Analysis – by Application

8.1 Cell Line Engineering

8.1.1 Overview
8.1.2 Cell Line Engineering: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Genetic Engineering

8.2.1 Overview
8.2.2 Genetic Engineering: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Diagnostic Applications

8.3.1 Overview
8.3.2 Diagnostic Applications: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Drug Discovery

8.4.1 Overview
8.4.2 Drug Discovery: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Genome Editing Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Academic and Research Institutes

9.2.1 Overview
9.2.2 Academic and Research Institutes: North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Clinical Research Organizations

9.3.1 Overview
9.3.2 Clinical Research Organizations : North America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Genome Editing Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Genome Editing Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Genome Editing Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Genome Editing Market Breakdown, by Technology
10.2.1.1.2 US: North America Genome Editing Market Breakdown, by Application
10.2.1.1.3 US: North America Genome Editing Market Breakdown, by End User

10.2.1.2 Canada: North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Genome Editing Market Breakdown, by Technology
10.2.1.2.2 Canada: North America Genome Editing Market Breakdown, by Application
10.2.1.2.3 Canada: North America Genome Editing Market Breakdown, by End User

10.2.1.3 Mexico : North America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Genome Editing Market Breakdown, by Technology
10.2.1.3.2 Mexico : North America Genome Editing Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Genome Editing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Lonza

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Horizon Discovery Group plc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Integrated DNA Technologies

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 GenScript

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Eurofins Scientific

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 CRISPR Therapeutics

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Editas Medicine

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Genome Editing Market